Entering text into the input field will update the search result below

Bellicum Pharmaceuticals EPS of -$18.99

  • Bellicum Pharmaceuticals (NASDAQ:BLCM): Q4 EPS of -$18.99 may not be comparable to consensus of -$0.37.
  • Revenue of $15K (-98.1% Y/Y).
  • Press Release

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About BLCM

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
Bellicum Pharmaceuticals, Inc.
Salarius Pharmaceuticals, Inc.
Allarity Therapeutics, Inc.
Phio Pharmaceuticals Corp.
ZyVersa Therapeutics, Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.